Yes, Porhon. Seems to be a very clear thing in the literature. Just one sentence by Pati S et al in Transfusion, 16 July 2021: "Early study of the pathologic effects of the SARS-CoV-2 virus reveal profound hypercoagulability and an endotheliopathy resulting in secondary organ failure likely due to microthrombi and endothelial dysfunction".
NEW PAPER about ATH434 and endothelial cells !!!!, page-6
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $17.8K | 3.6M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 66 | 75025101 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27379258 | 24 |
View Market Depth
| Last trade - 10.32am 27/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |